CI Global Health Sciences Corporate Class

Series EF CAD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date August 2015
CAD Total net assets ($CAD)
As at 2026-03-31
$135.1 million
NAVPS
As at 2026-05-08
$8.6817
MER (%)
As at 2025-09-30
1.14
Management fee (%) 0.88
Asset class Sector Equity
Currency CAD
Minimum investment $100,000 initial/$5,000 additional
Distribution frequency Quarterly
Last distribution $0.1561

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

EF 15005
A ISC 201
DSC SO* 701
LL SO 1701
E 16005
F 224
I 886
O 18005
P 90024
*No new purchases directly into switch only funds.

Performance2 As at 2026-04-30

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
-10.85% -3.59% -10.06% -6.61% -2.25% -1.06% -0.66% 3.22% 0.69%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.1561
2021-03-26 0.0536
2020-12-18 0.0865
2020-09-25 0.0859
2020-06-26 0.0640
Payable date Total
2020-03-20 0.1570
2019-12-13 0.0898
2019-09-27 0.1006
2019-06-21 0.0945
2019-03-22 0.1508

CI PREFERRED PRICING4

Investment amount Combined fee reduction
$100,000 - $250,000 0.00%
$250,000 - $500,000 0.03%
$500,000 - $1,000,000 0.08%
$1,000,000 - $2,500,000 0.18%
$2,500,000 - $5,000,000 0.23%
$5,000,000 and above 0.30%

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series EF CAD
 
Portfolio allocations5 As at 2026-03-31
Asset allocation (%)
  • US Equity 81.98
  • International Equity 14.59
  • Cash and Equivalents 3.44
  • Other -0.01
Sector allocation (%)
  • Healthcare 93.49
  • Cash and Cash Equivalent 3.44
  • Exchange Traded Fund 3.08
  • Other -0.01
Geographic allocation(%)
  • United States 81.95
  • United Kingdom 9.24
  • Canada 3.42
  • Switzerland 3.37
  • Netherlands 2.03
  • Other -0.01
Top holdings7
Sector (%)
1. Eli Lilly and Co Drugs 13.13%
2. AstraZeneca PLC Drugs 8.20%
3. Thermo Fisher Scientific Inc Healthcare Equipment 8.14%
4. Johnson & Johnson Drugs 7.92%
5. IQVIA Holdings Inc Drugs 6.64%
6. DexCom Inc Healthcare Equipment 5.65%
7. Intuitive Surgical Inc Healthcare Equipment 5.13%
8. Danaher Corp Healthcare Equipment 5.12%
9. Merck & Co Inc Drugs 4.86%
10. Stryker Corp Healthcare Equipment 4.84%
11. Boston Scientific Corp Healthcare Equipment 4.43%
12. CASH Cash and Cash Equivalent 3.41%
13. Vertex Pharmaceuticals Inc Drugs 3.39%
14. AbbVie Inc Drugs 3.15%
15. SPDR S&P Biotech ETF (XBI) Exchange Traded Fund 3.08%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.